CHRND

Chr 2ADAR

cholinergic receptor nicotinic delta subunit

Also known as: ACHRD, CMS2A, CMS3A, CMS3B, CMS3C, FCCMS, SCCMS

The delta subunit of the muscle acetylcholine receptor forms part of the pentameric receptor complex that opens an ion-conducting channel across the postsynaptic membrane following acetylcholine binding. Mutations cause congenital myasthenic syndromes (slow-channel, fast-channel, and acetylcholine receptor deficiency types) and multiple pterygium syndrome lethal type through both autosomal dominant and autosomal recessive inheritance patterns. The pathogenic mechanism involves gain-of-function effects that disrupt normal neuromuscular transmission.

Summary from RefSeq, OMIM, UniProt, Mechanism
Research Assistant →

Primary Disease Associations & Inheritance

?Myasthenic syndrome, congenital, 3A, slow-channelMIM #616321
AD
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiencyMIM #616323
AR
Multiple pterygium syndrome, lethal typeMIM #253290
AR
Myasthenic syndrome, congenital, 3B, fast-channelMIM #616322
AR
0
Active trials
10
Pubs (1 yr)
53
P/LP submissions
12%
P/LP missense
0.98
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCHRND
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
42 unique Pathogenic / Likely Pathogenic· 209 VUS of 400 total submissions
📖
GeneReview available — CHRND
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.98LOEUF
pLI 0.000
Z-score 1.65
OE 0.65 (0.450.98)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.05Z-score
OE missense 0.99 (0.901.09)
296 obs / 298.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.65 (0.450.98)
00.351.4
Missense OE0.99 (0.901.09)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 17 / 26.1Missense obs/exp: 296 / 298.6Syn Z: -0.06
DN
0.78top 25%
GOF
0.83top 10%
LOF
0.1993th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic17
VUS209
Likely Benign122
Benign7
Conflicting16
25
Pathogenic
17
Likely Pathogenic
209
VUS
122
Likely Benign
7
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
0
17
0
25
Likely Pathogenic
12
5
0
0
17
VUS
1
174
33
1
209
Likely Benign
0
8
63
51
122
Benign
0
1
6
0
7
Conflicting
16
Total2118811952396

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CHRND · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →